In 2024, biotech venture capital funding soared past pre – pandemic levels, as reported by EY, a top US authority source. A SEMrush 2023 study also shows a trend towards more selective funding. Navigating the pharmaceutical landscape involves understanding key areas like biotech venture capital, clinical trial management, drug patent…